ロード中...
Systemic treatments for metastatic cutaneous melanoma
BACKGROUND: The prognosis of people with metastatic cutaneous melanoma, a skin cancer, is generally poor. Recently, new classes of drugs (e.g. immune checkpoint inhibitors and small‐molecule targeted drugs) have significantly improved patient prognosis, which has drastically changed the landscape of...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2018
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491081/ https://ncbi.nlm.nih.gov/pubmed/29405038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011123.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|